People · Operator
Named in public records as an officer, director or promoter · active 2009–2014 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Putney Inc | — | Pharmaceuticals | Series B | $49.3M | $546.0M | 2009 |
B. Lance Sauerteig at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside B. Lance Sauerteig on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James A. Datin | 1 | 6 |
| John Berry | 1 | 3 |
| Stephen T. Zarrilli | 1 | 3 |
| Bruce L. Downey | 1 | 2 |
| Shyam S. Bhartia | 1 | 2 |
| Jean Hoffman | 1 | 2 |
| Brian Lance Stolz | 1 | 1 |
| E. Thomas Corcoran | 1 | 1 |
| Barry R. Edwards | 1 | 1 |
| Christopher Lewis | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.